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INTRODUCTION
Many treatment modalities are currently used for vitiligo, 
such as psoralen plus ultraviolet A (PUVA), narrowband 
ultraviolet B (NB-UVB), excimer lasers, topical steroids, 
topical immunomodulators, and calcipotriol. In patients 
with stable leucoderma (e.g., segmental vitiligo), surgical 
methods can be alternative therapeutic options. These 
surgical techniques are based on a common principle: 
to transplant autologous melanocytes from a normal 
pigmented donor skin to depigmented area. Many 
surgical techniques for repigmenting vitiligo have been 
devised over the years and can be broadly divided into 
tissue and cellular grafting. Tissue grafts include full-
thickness punch grafts, thin dermoepidermal grafts, 
and suction epidermal grafting. With these tissue 
grafts, only a limited surface area can be treated per 
treatment session. Cellular grafts include cultured pure 
melanocytes suspension and non-cultured epidermal 
cellular suspensions (mixture of melanocytes and 
keratinocytes). These epidermal cells can also be co-
cultured to epithelial sheet grafts. The major advantage 
of these suspension and culturing techniques is that, 
they permit treatment of affected skin manifold larger 
than the donor area. However, culturing techniques are 
time consuming, expensive due to the culturing time of 
several weeks, and require highly trained personnel and 
well-equipped tissue laboratories. Furthermore, the use 
of specific growth factors and additives in the culture 
medium (e.g., 12-O-tetradecanoyl-phorbol 13-acetate/
TPA), pose safety concerns. These limitations were 
overcome with the introduction of the non-cultured 
cellular grafting techniques in 1992 by Gauthier and 
Surleve-Bazeille.[1] With this technique a cellular 
suspension is used without first expanding the cells in 
culture. Larger areas (8-to10-fold size of donor skin), can 
be treated and the procedure can be completed in several 
hours in an outpatient basis. In a double-blind placebo-
controlled study, published in 2004, we demonstrated 
that repigmentation was primarily induced by the 
transplanted melanocytes and not by the skin abrasion. [2] 
This has also been reported earlier by Olsson et al.[3-4] 
Since the description of the original procedure in 1992, 
many reports followed, including several modifications 
and further simplifications. The purpose of this review 
is to give an overview of the literature with respect to 
treatment outcome and developments in the technical 
procedure of non-cultured cellular grafting in vitiligo.
METHODS FOR DATA COLLECTION
The computerized bibliographical databases Pubmed 
(U.S. National Library of Medicine; National Institutes of 
Health) was screened for clinical trials from January 1960 
to July 2010. The main keywords used were “vitiligo, 
grafting, melanocyte grafting, surgery, melanocyte 
transplantation, non-cultured epidermal grafting.” 
Other data sources were the reference lists from articles 
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retrieved. Only the clinical trials on non-cultured 
epidermal cellular grafting (using trypsin) for vitiligo 
(segmental, generalized, mixed) and in addition, other 
types of leucoderma (halo nevi, nevus depigmentosus, 
chemical leucoderma, piebaldism) were included. Single 
case reports were not included. All publications were 
classified by level of evidence (CBO/EBRO guidelines, 
Utrecht, The Netherlands).
Classification level of evidence (CBO/EBRO 
guidelines, Utrecht, The Netherland)
A1 Meta-analysis containing at least some trials of level A2 and of 
which the results of individual trials are consistent
A2 Randomized comparative clinical trials of good quality (randomized 
double-blind controlled trials) of sufficient size and consistency
B Randomized clinical trials of moderate (weak) quality or insufficient 
size or other comparative trials (non-randomized, cohort studies, 
patient–control studies)
C Non-comparative trials
D Expert opinion
Results of literature review
In total, 21 studies were obtained using the database 
[Table 1]. Most of them (16) were publications of level 
of evidence C, 3 of evidence level B, 2 of evidence level 
A2, and none of evidence level A1.
General information with respect to non-
cultured epidermal cellular grafting
It is generally agreed, according to the collected literature 
that, several prerequisites are necessary for vitiligo patients 
to be eligible for cellular transplantation. Proper selection 
of patients is an essential requirement for successful 
repigmentation. The most important selection criterion is 
the stability of the disease. According to the majority of 
authors, vitiligo can be classified as being “stable,” when 
progression of old lesions and/or development of new 
lesions are/is absent in the past one year. As segmental 
vitiligo stabilizes spontaneously, in general, within the 
first year of onset, this remains the best surgical treatment 
indication.[5] Only a minority of patients with generalized 
vitiligo are suitable for a surgical intervention, as this type 
of vitiligo in general extends over time. Before treatment 
is initiated in patients with generalized vitiligo, it has to 
be pointed out that the intervention does not alter the 
underlying patho-aetiology and, despite the treatment, 
the natural course of the disease remains the same. 
Furthermore, the patients should not have a history of 
a hypertrophic scars and preferably have no signs of a 
Koebner phenomenon because the latter may negatively 
influence surgical treatment results.[2]
Technical procedure of non-cultured cellular 
grafting
In the original description of the procedure, a donor 
sample was obtained from the scalp by superficial 
shaving using a dermatome with a razor blade and 
then treated with trypsin 0.25% for 18 h for dermo-
epidermal separation.[1] Subsequently, epidermal cells 
were extracted and a cellular suspension was prepared. 
This suspension was inoculated into blisters raised 
with liquid nitrogen at the recipient area. The roof of an 
intact blister served as a natural dressing that held the 
transplanted cells in place.
In 1998, Olsson and colleagues described a comparable 
technique, but the donor skin was taken from the gluteal 
region using a Goulian biopsy knife. The time for 
trypsinization was reduced to 50 min and the cellular 
suspension was directly applied onto a dermabraded 
vitiligo lesion. This made it possible to perform the whole 
procedure on the same day.[6] A crucial limiting factor of 
this grafting technique, at least in our experience, was the 
fixation of the liquid suspension at the recipient area. To 
overcome this problem, we introduced hyaluronic acid 
as a biodegradable cell carrier to increase the viscosity 
of the suspension.[7] 
Advances in the procedure were also made in the 
preparation of the recipient area. De-epithelization of the 
graft recipient area bed can be achieved by cryotherapy, 
induction of suction blisters or dermabrasion using a 
high-speed dermabrader. However, for more delicate 
or critical anatomic areas (e.g., eyelid) and for irregular 
or spotted lesions, laser abrasion [e.g., erbium:YAG or 
carbon dioxide (CO2) laser] can be a better alternative, 
as it offers excellent precision over margin and depth 
control. A histological study, comparing pulsed CO2 laser 
abrasion with conventional dermabrasion (standard Hall 
dermabrader burr) demonstrated that tissue destruction 
of the dermis was similar and that short-pulsed CO2 
laser abrasion did not cause significant thermal necrosis 
on the surface of the papillary dermis to interfere with 
a satisfactory graft take.[8] However, for suction blister 
grafting, better results were achieved on recipient sites 
previously prepared with the suction blister technique 
compared to CO2 laser abrasion in a single case report.[9] 
But, the preferred technique for recipient area depends 
upon the choice of the surgeon. 
There is ongoing research to simplify the procedure of 
non-cultured cellular grafting, and modifications with 
respect to safety of the procedure should further be taken 
into account [Figure 1a-c]. At least in our experience, 
the use of special culture media can be replaced by 
phosphate-buffered saline (PBS) or saline solution 
without xenobiotics (e.g., bovine serum or pituitary 
extract or other foreign proteins). Bovine serum, as a 
neutralizing agent for trypsin, can be substituted by 
soybean-derived trypsin inhibitor or autologous human 
serum drawn from the patient. To further simplify the 
laboratory procedure, one could also use the simplified 
cellular grafting technique described by Goh et al.[10] This 
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modification reduces cell preparation time, amount of 
reagents needed and costs, and obviates the need of a 
laboratory for extraction of cells. With this technique, 
the extraction of epidermal cells from the donor skin 
is performed by using an inexpensive 6-well plate, a 
microfilter, and 3 reagents: trypsin, soybean trypsin 
inhibitor, and PBS. A comparable commercial kit (ReCell 
kit) is also available for the extraction of epidermal cells 
without the need of a laboratory.[11] However, this kit 
is expensive, which limits its use for routine use. One 
comparison study (n=5) between the commercial kit and 
the conventional method of cell suspension preparation, 
suggests that repigmentation was comparable for both 
the techniques used.[11] However, comparable studies on 
larger study populations are still missing. 
The most simplified method would be to replace the 
enzymatic preparation of a cellular suspension by 
mechanical separation of epidermal cells. This is reported 
by Kachhawa, in which he uses epidermal scrapings (till 
the level of the papillary dermis) to apply directly onto 
the dermabraded recipient area.[12] However, questions 
regarding the homogeneity of the repigmentation, 
possible multiplication factor from donor skin to 
treatment area and treatment outcome on larger surface 
areas remain to be investigated. 
Treatment results 
With increasing experience, cumulative data on the 
outcome of non-cultured cellular grafting in the 
treatment of vitiligo and other types of leucoderma 
began to emerge. A summary of the literature, including 
treatment outcomes of different types of leucoderma, is 
show in Table 1. The repigmentation rates vary widely 
within the different publications (>75% repigmentation 
in 27-100% of patients). However, this might be explained 
by the fact that many differences exist among the studies, 
for example, different follow-up periods (1 month to 7 
years), different characteristics of the included study 
populations (disease activity, treatment indication, 
treatment localization, Koebner phenomenon), different 
evaluation methods to assess repigmentation used, as 
well as variations in preparation of the cell suspension 
and post-operative treatment. This heterogeneity makes 
comparison among the studies difficult. However, 
several conclusions can be drawn from the available 
literature. Best results were in general, achieved in 
patients with completely stable leucoderma (segmental 
vitiligo [Figure 2a-b] and piebaldism). Anatomic sites 
that showed good repigmentation response were face/
neck and trunk, while more resistant sites include the 
fingers and lips. Repigmentation of these “lip-tip” areas 
was more successfully achieved with mini-grafting, 
suggesting that the dermal component of the graft may 
influence treatment outcome. Mulekar et al, reported, 
more recently, good results with epidermal cellular 
grafting on “more difficult-to-treat sites” too (fingers, 
toes, elbows, …), but they mentioned that multiple 
sessions were often necessary.[13]
Repigmentation rates for segmental vitiligo is in general 
consistently high, regardless of cell preparation or 
dermabrasion technique used, while results in generalized 
vitiligo is variable and often more disappointing. Only 
one study included mixed vitiligo patients, but achieved 
inferior results in this group of patients.[5] The importance 
of disease stability has been demonstrated by many 
authors and most likely explains the poor results as 
achieved by Back et al.[14] In their randomized controlled 
trial, 69% of the 13 included patients, had an active 
generalized vitiligo. Furthermore, Koebner phenomenon 
was observed in 77% of their patients, which is known 
as an essential negatively influencing factor for surgical 
treatment outcome in vitiligo.[2,15] 
Adverse effects
Reported adverse effects on recipient and donor areas are 
in general minimal or absent according to the available 
literature. However, a frequently reported limitation is 
the presence of colour mismatch between the treated area 
and the surrounding skin. We described in a long-term 
follow-up study on non-cultured cellular grafting, the 
presence of some colour mismatch at the recipient area 
(hyper- and hypo-pigmentation) in 80.4% of 54 evaluated 
patients.[5] But, this colour mismatch was not disturbing 
according to the majority of these patients. At the donor 
site minor textural skin changes were observed in this 
study in 65% of the patients.[5] The majority of these 
patients accepted this side effect without any problem, 
as this was almost not visible by clinical inspection. 
Hyperpigmentation at the donor site, has been reported 
too by several authors.[16] 
Long-term results
Long-term follow-up studies on non-cultured epidermal 
cell transplantation suggest that it is effective and safe, 
particularly for repigmenting stable and localized types 
of leucoderma. Olsson and Juhlin reported in their follow-
up study (1–7 years), results of 52 treated locations. [15] For 
segmental vitiligo and piebaldism, all patients achieved 
and retained 95%–100% repigmentation. However, for 
generalized vitiligo, they achieved only an average 
repigmentation of 49% in long-term evaluation. Similar 
results were reported by Mulekar (follow-up period of 
1–5 years).[17] They reported good results in segmental 
and focal vitiligo. Repigmentation was retained until 
the end of the respective follow-up period. In our long-
term follow-up study (1–7.7 years), repigmentation 
was retained in 93.3% of the grafted areas. [5] Loss of 
pigmentation was only observed by generalized vitiligo 
patients and not in segmental vitiligo, piebaldism, and 
halo nevi and nevus depigmentosus. 
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CONCLUSION
A review of the available literature was performed 
to assess the effectiveness and developments in the 
technical procedure of non-cultured cellular grafting. 
Non-cultured epidermal cell transplantation provides 
the possibility to repigment vitiliginous skin manifold 
larger than the donor skin and can be completed in 
several hours on an outpatient basis. The selection of 
patients plays a significant role in achieving a successful 
repigmentation. Results are excellent in segmental 
vitiligo, halo nevi, piebaldism, and less in generalized 
vitiligo. Differences in these selection criteria may 
explain the variation in treatment outcome. Although 
this technique offers many advantages compared with 
the other surgical techniques, it requires highly trained 
personnel and well-equipped facilities. However, 
several advances have been made in recent years with 
respect to simplification of the laboratory procedure 
and safety. 
REFERENCES
1. Gauthier Y, Surleve-Bazeille JE. Autologous grafting with non-cultured 
melanocytes: A simplified method for treatment of depigmented 
lesions. J Am Acad Dermatol 1992;26:191-4.
2. van Geel N, Ongenae K, De Mil M, Haeghen YV, Vervaet C, Naeyaert 
JM. Double-blind placebo-controlled study of autologous transplanted 
epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol 
2004;140:1203-8.
3. Olsson MJ, Juhlin L. Melanocyte transplantation in vitiligo. Lancet 
1992;340:981.
4. Olsson MJ, Juhlin L. Repigmentation of vitiligo by transplantation of 
cultured autologous melanocytes. Acta Derm Venereol 1993;73:49-51.
5. van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long term results of 
non cultured epidermal cellular grafting in vitiligo, halo nevi, piebaldism 
and nevus depigmentosus. Br J Dermatol 2010 163(6):1186-93.
6. Olsson MJ, Juhlin L. Leucoderma treated by transplantation of a basal 
cell layer enriched suspension. Br J Dermatol 1998;138:644-8.
7. van Geel N, Ongenae K, De Mil M, Naeyaert JM. Modified technique 
of autologous non-cultured epidermal cell transplantation for 
repigmenting vitiligo: A pilot study. Dermatol Surg 2001;27:873-6.
8. Kahn AM, Ostad A, Moy RL. Grafting following short-pulse carbon 
dioxide laser de-epithelialization. Dermatol Surg 1996;22:965-7.
9. Lee DY, Choi SC, Lee JH. Comparison of suction blister and carbon 
dioxide laser for recipient site preparation in epidermal grafting of 
segmental vitiligo. Clin Exp Dermatol 2010;35:328-9.
Geel, et al.: Cellular grafting in vitiligo
Figure 1: Preparation of non-cultured epidermal cellular 
suspension at Ghent University Hospital, Belgium; (a) 
Dermo-epidermal separation after trypsinization; (b) 
obtained cell pellet; and (c) cell suspension application on 
recipient area
a
b
c
Figure 2: (a) A patient with segmental vitiligo on the right 
arm; (b) Repigmentation after non-cultured cellular grafting
a b
Journal of Cutaneous and Aesthetic Surgery - Jan-Apr 2011, Volume 4, Issue 122
10. Goh BK, Chua XM, Chong KL, de Mil M, van Geel NA. Simplified cellular 
grafting for treatment of vitiligo and piebaldism: The "6-well plate" 
technique. Dermatol Surg 2010;36:203-7.
11. Mulekar SV, Ghwish B, Al Issa A, Al Eisa A. Treatment of vitiligo lesions 
by ReCell vs. conventional melanocyte-keratinocyte transplantation: A 
pilot study. Br J Dermatol 2008;158:45-9.
12. Kachhawa D, Kalla G. Keratinocyte-melanocyte graft technique followed 
by PUVA therapy for stable vitiligo. Indian J Dermatol Venereol Leprol 
2008;74:622-4.
13. Mulekar SV, Al Issa A, Al Eisa A. Treatment of vitiligo on difficult-to-
treat sites using autologous non-cultured cellular grafting. Dermatol 
Surg 2009;35:66-71.
14. Back C, Dearman B, Li A, Neild T, Greenwood JE. Non-cultured 
keratinocyte/melanocyte cosuspension: Effect on reepithelialization 
and repigmentation--a randomized, placebo-controlled study. J Burn 
Care Res 2009;30:408-16.
15. Olsson MJ, Juhlin L. Long-term follow-up of leucoderma patients 
treated with transplants of autologous cultured melanocytes, ultrathin 
epidermal sheets and basal cell layer suspension. Br J Dermatol 
2002;47:893-904.
16. Mulekar SV, Al Eisa A, Delvi MB, Al Issa A, Al Saeed AH. Childhood 
vitiligo: A long-term study of localized vitiligo treated by non-cultured 
cellular grafting. Pediatr Dermatol 2010;27:132-6.
17. Mulekar SV. Long-term follow-up study of segmental and focal vitiligo 
treated by autologous, non-cultured melanocyte-keratinocyte cell 
transplantation. Arch Dermatol 2004;140:1211-5.
18. Issa CM, Rehder J, Taube MB. Melanocyte transplantation for the 
treatment of vitiligo: Effects of different surgical techniques. Eur J 
Dermatol 2003;13:34-9.
19. Mulekar SV. Melanocyte-keratinocyte cell transplantation for stable 
vitiligo. Int J Dermatol 2003;42:132-6.
20. Mulekar SV. Long-term follow-up study of 142 patients with vitiligo 
vulgaris treated by autologous, non-cultured melanocyte-keratinocyte 
cell transplantation. Int J Dermatol 2005;44:841-5.
21. Pandya V, Parmar KS, Shah BJ, Bilimoria FE. A study of autologous 
melanocyte transfer in treatment of stable vitiligo. Indian J Dermatol 
Venereol Leprol 2005;71:393-7.
22. Xu AE, Wei XD, Cheng DQ, Zhou HF, Qian GP. Transplantation of 
autologous non-cultured epidermal cell suspension in treatment of 
patients with stable vitiligo. Chin Med J (Engl) 2005;118:77-9.
23. Tegta GR, Parsad D, Majumdar S, Kumar B. Efficacy of autologous 
transplantation of non-cultured epidermal suspension in two different 
dilutions in the treatment of vitiligo. Int J Dermatol 2006;45:106-10.
24. van Geel N, Ongenae K, Vander Haeghen Y, Vervaet C, Naeyaert JM. 
Subjective and objective evaluation of non-cultured epidermal cellular 
grafting for repigmenting vitiligo. Dermatology 2006;213:23-9.
25. Cervelli V, De Angelis B, Balzani A, Colicchia G, Spallone D, Grimaldi 
M. Treatment of stable vitiligo by ReCell system. Acta Dermatovenerol 
Croat 2009;17:273-8.
26. El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied 
MM, et al. Autologous melanocyte-keratinocyte suspension in the 
treatment of vitiligo. J Eur Acad Dermatol Venereol 2011;25:215-20
How to cite this article: Geel Nv, Goh BK, Wallaeys E, Keyser SD, 
Lambert J. A review of non-cultured epidermal cellular grafting in vitiligo. 
J Cutan Aesthet Surg 2011;4:17-22.
Source of Support: Nil. Conflict of Interest: None declared.
Geel, et al.: Cellular grafting in vitiligo
Author Help: Reference checking facility
The manuscript system (www.journalonweb.com) allows the authors to check and verify the accuracy and style of references. The tool checks 
the references with PubMed as per a predefined style. Authors are encouraged to use this facility, before submitting articles to the journal.
•	 The style as well as bibliographic elements should be 100% accurate, to help get the references verified from the system. Even a 
single spelling error or addition of issue number/month of publication will lead to an error when verifying the reference. 
•	 Example of a correct style
 Sheahan P, O’leary G, Lee G, Fitzgibbon J. Cystic cervical metastases: Incidence and diagnosis using fine needle aspiration biopsy. 
Otolaryngol Head Neck Surg 2002;127:294-8. 
•	 Only the references from journals indexed in PubMed will be checked. 
•	 Enter each reference in new line, without a serial number.
•	 Add up to a maximum of 15 references at a time.
•	 If the reference is correct for its bibliographic elements and punctuations, it will be shown as CORRECT and a link to the correct 
article in PubMed will be given.
•	 If any of the bibliographic elements are missing, incorrect or extra (such as issue number), it will be shown as INCORRECT and link to 
possible articles in PubMed will be given. 
